Özge Başaran

1.2k total citations
94 papers, 583 citations indexed

About

Özge Başaran is a scholar working on Molecular Biology, Surgery and Hematology. According to data from OpenAlex, Özge Başaran has authored 94 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 29 papers in Surgery and 23 papers in Hematology. Recurrent topics in Özge Başaran's work include Inflammasome and immune disorders (30 papers), Autoimmune and Inflammatory Disorders Research (21 papers) and Kawasaki Disease and Coronary Complications (13 papers). Özge Başaran is often cited by papers focused on Inflammasome and immune disorders (30 papers), Autoimmune and Inflammatory Disorders Research (21 papers) and Kawasaki Disease and Coronary Complications (13 papers). Özge Başaran collaborates with scholars based in Türkiye, United States and Antigua and Barbuda. Özge Başaran's co-authors include Nilgün Çakar, Nermin Uncu, Mehmet Haberal, Yelda Bilginer, Ezgi Deniz Batu, Seza Özen, Ümmüşen Kaya Akça, Gökhan Moray, Müşerref Kasap Cüceoğlu and Seher Şener and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Özge Başaran

76 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Özge Başaran Türkiye 13 206 158 115 111 109 94 583
Federica Vanoni Switzerland 15 238 1.2× 108 0.7× 169 1.5× 68 0.6× 112 1.0× 31 650
Lourdes Mateo Spain 17 80 0.4× 276 1.7× 113 1.0× 70 0.6× 79 0.7× 88 860
Santiago Jiménez Spain 15 179 0.9× 160 1.0× 107 0.9× 62 0.6× 24 0.2× 42 624
E. Abderrahim Tunisia 15 75 0.4× 233 1.5× 97 0.8× 132 1.2× 130 1.2× 135 802
Young Seo Park South Korea 20 155 0.8× 136 0.9× 68 0.6× 61 0.5× 224 2.1× 91 1.1k
Mark Harber United Kingdom 19 67 0.3× 84 0.5× 142 1.2× 52 0.5× 78 0.7× 53 888
Sevinç Emre Türkiye 15 298 1.4× 91 0.6× 85 0.7× 63 0.6× 221 2.0× 43 990
Priya S. Verghese United States 15 56 0.3× 159 1.0× 111 1.0× 156 1.4× 58 0.5× 56 842
E Leatham United Kingdom 10 76 0.4× 322 2.0× 196 1.7× 83 0.7× 87 0.8× 17 839
Marie Matignon France 20 48 0.2× 257 1.6× 206 1.8× 188 1.7× 185 1.7× 62 965

Countries citing papers authored by Özge Başaran

Since Specialization
Citations

This map shows the geographic impact of Özge Başaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özge Başaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özge Başaran more than expected).

Fields of papers citing papers by Özge Başaran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özge Başaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özge Başaran. The network helps show where Özge Başaran may publish in the future.

Co-authorship network of co-authors of Özge Başaran

This figure shows the co-authorship network connecting the top 25 collaborators of Özge Başaran. A scholar is included among the top collaborators of Özge Başaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özge Başaran. Özge Başaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Başaran, Özge, et al.. (2025). Validation of the EULAR/ACR classification criteria for chronic nonbacterial osteomyelitis in a pediatric cohort. Clinical Rheumatology. 44(10). 4229–4236.
2.
Sağ, Erdal, et al.. (2025). Re-evaluation of MEFV carriers previously diagnosed with FMF: a colchicine discontinuation study. Lara D. Veeken. 64(11). 5726–5732.
3.
Batu, Ezgi Deniz, et al.. (2024). A treatment algorithm for familial Mediterranean fever patients with menstruation-associated attacks. Lara D. Veeken. 64(3). 1341–1346. 2 indexed citations
4.
Şener, Seher, Ezgi Deniz Batu, Ümmüşen Kaya Akça, et al.. (2024). Differentiating Multisystem Inflammatory Syndrome in Children from Kawasaki Disease During the Pandemic. Turkish Archives of Pediatrics. 59(2). 150–156. 2 indexed citations
5.
Şener, Seher, Erdal Atalay, Adalet Elçin Yıldız, et al.. (2023). Subclinical enthesitis in enthesitis-related arthritis and sacroiliitis associated with familial Mediterranean fever. Modern Rheumatology. 34(3). 607–613. 3 indexed citations
6.
Akça, Ümmüşen Kaya, Ezgi Deniz Batu, Erdal Atalay, et al.. (2023). Patients Without a Rheumatic Disease Diagnosis in a Pediatric Rheumatology Unit: Retrospective Analysis and Comparison Between Pre-pandemic and Pandemic Periods. Turkish Archives of Pediatrics. 58(1). 49–55. 1 indexed citations
7.
Akça, Ümmüşen Kaya, Erdal Sağ, Büşra Aydın, et al.. (2023). Chronic non-bacterial osteomyelitis and immune checkpoint molecules. Clinical Rheumatology. 43(1). 553–560.
8.
Şener, Seher, Ezgi Deniz Batu, Müşerref Kasap Cüceoğlu, et al.. (2023). Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever. Lara D. Veeken. 62(11). 3700–3705. 6 indexed citations
9.
Cüceoğlu, Müşerref Kasap, Özge Başaran, Özge Soyer, & Seza Özen. (2022). Hypersensitivity to Biological Treatments in Juvenile Idiopathic Arthritis: How Should It Be Managed?. Journal of Clinical Medicine. 11(24). 7291–7291.
10.
Gürlevik, Sibel Laçinel, Yasemin Özsürekçi, Erdal Sağ, et al.. (2022). The difference of the inflammatory milieu in MIS-C and severe COVID-19. Pediatric Research. 92(6). 1805–1814. 25 indexed citations
11.
Batu, Ezgi Deniz, Ümmüşen Kaya Akça, Özge Başaran, Yelda Bilginer, & Seza Özen. (2022). Probiotic use in the prophylaxis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a retrospective cohort study. Rheumatology International. 42(7). 1207–1211. 11 indexed citations
12.
Acar, Banu Çelikel, et al.. (2021). Is the performance of the international severity scoring system for familial mediterranean fever in children better than other scoring systems?. International Journal of Clinical Practice. 75(11). e14678–e14678. 4 indexed citations
13.
Başaran, Özge, et al.. (2021). Rare Autoinflammatory Diseases. Turkish Archives of Pediatrics. 57(1). 18–25. 7 indexed citations
14.
Aydın, Fatma, Banu Çelikel Acar, Nermin Uncu, et al.. (2020). Takayasu Arteritis: A Case Presenting With Neurological Symptoms and Proteinuria. Archives of Rheumatology. 35(2). 287–291. 1 indexed citations
15.
Başaran, Özge, Nermin Uncu, Nilgün Çakar, et al.. (2018). C3 glomerulopathy in NLRP12-related autoinflammatory disorder: case-based review. Rheumatology International. 38(8). 1571–1576. 12 indexed citations
16.
Gür, Gökçe, et al.. (2016). Hemorragia pulmonar, una complicación poco frecuente en una niña con púrpura de Schönlein-Henoch. Archivos Argentinos de Pediatria. 114(5). e366–9. 1 indexed citations
17.
Başaran, Özge, et al.. (2016). Familial Mediterranean fever associated with optic neuritis, successfully treated with anti-interleukin 1 agents. The Turkish Journal of Pediatrics. 58(3). 327–330. 7 indexed citations
18.
Başaran, Özge, et al.. (2006). Burns in Turkish children and adolescents: Nine years of experience. Burns. 33(1). 46–51. 51 indexed citations
19.
Moray, Gökhan, et al.. (2004). Immunosuppressive therapy and kaposi's sarcoma after kidney transplantation. Transplantation Proceedings. 36(1). 168–170. 17 indexed citations
20.
Başaran, Özge, H. Karakayalı, R Emiroğlu, et al.. (2003). Donor safety and quality of life after left hepatic lobe donation in living-donor liver transplantation. Transplantation Proceedings. 35(7). 2768–2769. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026